• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Generics

    Mallinckrodt Spins Off Par Health, Launches Keenova Therapeutics

    PR NEWSWIRE

    Endo Introduces Sole Generic RAVICTI Oral Liquid in US

    PR NEWSWIRE

    Mallinckrodt Publishes Real-World Insights on Acthar Gel

    PR NEWSWIRE

    Mallinckrodt, Endo Plan Leadership Team for Merged Company

    PR NEWSWIRE

    Lupin appoints Spiro Gavaris as president of US generics biz

    ECONOMIC TIMES

    Mallinckrodt revises plans for generic business spin-off

    IN-PHARMATECHNOLOGIST

    Mallinckrodt to spin off generics business, but to keep options open

    REUTERS

    Mydayis®(Amphetamine) : Shire Development v. Specgx

    PATENT LITIGATION

    Intas low-balls Mallinckrodt unit bid to $1bn on legal fears

    ECONOMIC TIMES

    Xyrem®( Sodium Oxybate): Jazz Pharmaceuticals V. Mallinckrodt

    PATENT LITIGATION

    Intas closing in on Mallinckrodt’s US generics business

    ECONOMIC TIMES

    Aurobindo Pharma, Intas in race to buy Mallinckrodt`s US generic business

    MONEYCONTROL

    As drug prices drop, generics makers fight back with deals

    REUTERS

    FDA moves signal storm warning for pharma firms

    THEHINDU

    Ofirmev (Acetaminophen): Mallinckrodt Ip V.B. Braun Medical Inc.

    PATENT LITIGATION

    Ofirmev (Acetaminophen): Mallinckrodt & SCR Pharmatop v. B. Braun Medical

    PATENT LITIGATION

    3 Top Generic Drug Companies to Buy in 2017

    FOOL

    Mylan cuts short J&J`s Concerta generics reprieve with new FDA nod

    FIERCE PHARMA

    Generic Drug Makers Challenge FDA Plan to Withdraw their ADHD Pills

    STAT

    Generic opioids are cheap. Alternative drugs, not so much

    FIERCE PHARMA

    Vyvanse set to steal ADHD share in back-to-school meds rush

    FIERCE PHARMA MARKETING

    Boehringer charges ahead with sale of U.S. generics biz with bids from Hikma, Mallinckrodt

    FIERCE PHARMA

    FDA balks on generic Concerta as Mallinckrodt, Actavis meds gobble up market

    FIERCE PHARMA

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.